Credo Technology Group Holding Ltd vs Herbalife Nutrition Ltd — how do they compare? Credo Technology Group Holding Ltd trades at $215.83 (market cap $39.82B), while Herbalife Nutrition Ltd trades at $12.86 (market cap $1.34B). The key difference: Credo Technology Group Holding Ltd is far larger — about 29.7× Herbalife Nutrition Ltd's market cap, and Credo Technology Group Holding Ltd is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Credo Technology Group Holding Ltd for 22 Days and Herbalife Nutrition Ltd for 43 Days on average.
| CRDO | HLF | |
|---|---|---|
Market Cap | $39.82B | $1.34B |
Volume | 9,451,558 | 1,589,457 |
Sector | Technology | Consumer Staples |
52-Week High | $302.52 | $19.96 |
52-Week Low | $87.81 | $7.75 |
Typical Hold Time | 22 Days | 43 Days |
Enterprise Value | $39.08B | $3.18B |
Signals from Pluang's Aura AI — not financial advice
CRDO trades at $212.42, down 3.45% today but maintains strong technical support near $204 with bullish moving averages. The company demonstrates exceptional fundamentals with 114.7% YoY revenue growth (Seeking Alpha, 2026-09-25) and 33.83% net margins, though valuation remains elevated at P/E of 74.6. Recent earnings beats and AI infrastructure demand drive positive sentiment.
Outlook remains positive given triple-digit revenue growth and $267.33 analyst price target (87.5% buy ratings), but premium valuation and customer concentration pose risks. The stock offers exposure to AI connectivity chip demand with potential for 26% upside to consensus target, though execution risks require monitoring.
Herbalife (HLF) trades at $12.86, up 1.62% on the day, with a bullish technical signal and a consensus analyst price target of $19.00 implying significant upside. The company reported Q2 2026 EPS of $0.51, missing expectations, but reaffirmed full-year 2026 guidance. Financials show a net income margin of 3.16% for 2025, with a low P/E of 8.22 and P/S of 0.26, suggesting potential undervaluation. Recent news includes a $250 million share repurchase authorization and a planned CEO transition effective October 31, 2026.
The outlook for HLF is cautiously optimistic, with valuation metrics and analyst sentiment supporting a bullish case, but risks include recent earnings misses, high debt levels, and ongoing leadership changes. The stock presents a value opportunity if the company can execute on its growth and margin expansion plans while managing its leverage.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.
Read more on CRDO →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →